Erschienen in:
01.10.2013 | Original Paper
Head-to-head comparison of 1 week versus 6 months CMR-derived infarct size for prediction of late events after STEMI
verfasst von:
Oliver Husser, Jose V. Monmeneu, Clara Bonanad, Cristina Gomez, Fabian Chaustre, Julio Nunez, Maria P. Lopez-Lereu, Gema Minana, Juan Sanchis, Luis Mainar, Vicente Ruiz, Maria J. Forteza, Isabel Trapero, David Moratal, Francisco J. Chorro, Vicente Bodi
Erschienen in:
The International Journal of Cardiovascular Imaging
|
Ausgabe 7/2013
Einloggen, um Zugang zu erhalten
Abstract
Infarct size (IS) at 1 week after ST-elevation myocardial infarction (MI) diminishes during the first months. The incremental prognostic value of IS regression and of scar size (SS) at 6 months is unknown. We compared cardiovascular magnetic resonance (CMR)-derived IS at 1 week and SS at 6 months after MI for predicting late major adverse cardiac events (MACE). 250 patients underwent CMR at 1 week and 6 months after MI. IS and SS were determined as the extent of transmural late enhancement (in >50 % of wall thickness, ETLE). During 163 weeks, 23 late MACE (cardiac death, MI or readmission for heart failure after the 6 months CMR) occurred. Patients with MACE had a larger IS at 1 week (6 [4–9] vs. 3 [1–5], p < .0001) and a larger SS at 6 months (5 [2–6] vs. 3 [1–5], p = .005) than those without MACE. Late MACE rates in IS >median were higher at 1 week (14 vs. 4 %, p = .007) and in SS >median at 6 months (12 vs. 5 %, p = .053). The C-statistic for predicting late MACE of CMR at 1 week and 6 months was comparable (.720 vs. .746, p = .1). Only ETLE at 1 week (HR 1.31 95 % CI [1.14–1.52], p < .0001, per segment) independently predicted late MACE. CMR-derived SS at 6 months does not offer prognostic value beyond IS at 1 week after MI. The strongest predictor of late MACE is ETLE at 1 week.